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We recently read the reply to the
Editor by Benedetto and associates,1
highlighting fundamental issues con-
cerning meta-analyses. Interestingly,
in an attempt to justify that meta-
analyses of randomized controlled
trials (RCTs) are the gold standard ev-
idence to address controversial issues,
they knowingly or unknowingly claim
that ‘‘no RCT has ever confirmed the
benefits of beating-heart coronary sur-
gery implied by observational stud-
ies.’’1 Unfortunately, this claim from
learned researchers like Benedetto
and associates is contrary to the cur-
rent best available evidence.2
Off-pump coronary artery bypass
(OPCAB) surgery, since its resurgence
in the early 1990s, has remained
a highly scrutinized technique. The
past decade was an era of trials and
tribulations for OPCAB with more
than 100 RCTs, over 300 observa-
tional studies, 60 propensity score
analyses, and same number of meta-
analyses of RCTs, as well as observa-
tional and propensity matched studies
verifying every aspect and outcome
of OPCAB. There is overwhelming
evidence from both meta-analyses of
RCTs as well as propensity score anal-
yses to confirm safety and efficacy of
OPCAB.2,3 The majority of these
RCTs and meta-analyses have shown
that outcomes of OPCAB are either
comparable or superior to on-pump cor-
onary artery bypass surgery.2,3 In fact,
OPCAB is associated with reductions
in the risks for stroke (50%), atrial
fibrillation (30%), wound infection
(48%), and acute kidney injury (70%).
OPCAB also reduces transfusion and
inotrope requirements, ventilation time,
intensive care unit and hospital stays,
and in-hospital and 1-year direct
costs.2,3
There is no denying the fact that,
whereas there is abundant evidence inThe Journalfavor of OPCAB, there is also evidence
that fails to show convincing benefits of
OPCAB.4 In view of the conflicting ev-
idence, there is a need for the cardiac
surgical community to call for a forum
andmake specific recommendations. If
it is agreed that the evidence is against
OPCAB, then those performing such
procedures should stop because they
are affecting the quality of care of thou-
sands of patients worldwide.5 If, on the
other hand, it is agreed that the evidence
for benefit of OPCAB is conclusive,
then the implications are of a different
order. However, until a verdict is
reached, as responsible researchers
and physicians it is important that we
adopt an unbiased approach to analyze
the available information’s content
for consistency, coherence, and clarity,
thereby differentiating facts from fads.
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To the Editor:
We thank Raja and associates for
their comments on our recent letter toof Thoracic and Cardiovascular SurgeEditor.1 In that letter, we observed
that in observational studies comparing
radial artery versus saphenous vein
graft, the better patency rate observed
for radial artery is surely biased by
native vessel quality. Randomization
avoids this important limitation. We
stated that the dangerous effect of se-
lection bias has also emerged in obser-
vational studies reporting beating-heart
bypass advantages over on-pump sur-
gery, which were not confirmed in ran-
domized controlled trials.2 Apparently,
Raja and associates did not like the lat-
ter statement.
However, this is not a personal
point of view but a fact that every
physician may read in a widely quoted
international cardiovascular journal.2
It is obvious that in surgical series,
beating-heart bypass has been prefer-
entially adopted when good quality
target vessels were present. This
aspect has heavily biased results in
retrospective analysis even when pro-
pensity analysis was adopted.
Results coming from randomized
controlled trials that compare not
similar but ‘‘exactly’’ the same pa-
tients reached the following conclu-
sions as reported in widely quoted
journals:
 No significant difference between
off-pump and on-pump coronary
artery bypass grafting in the rate
of the 30-day composite outcome;
the overall rate of graft patency
was lower in the off-pump group
than in the on-pump group.3
 No major differences in 30-day
outcomes in high-risk patients
randomized to off-pump versus
on-pump coronary bypass surgery:
the Best Bypass Surgery Trial.4
 Coronary artery bypass grafting
performed off-pump had lower
overall graft patency rate than on-
pump. Thirty-day complications,
neuropsychologic functioning, and
1-year clinical and functional out-
comes were not statistically differ-
ent between the 2 techniques.5ry c Volume 142, Number 3 723
